Although the AKT-BIM pathway is important in the chemo-sensitivity and apoptosis of cancer cells, whether AKT regulates BIM activity in ovarian cancer cells during ATO treatment remains unclear. The gene discussed is BCL2L11; the disease is ovarian cancer.